Castration-Resistant Prostate Cancer: Biological Mechanisms of Therapeutic Escape—On Behalf of the SIU Prostate Cancer Sub-Committee Panel
Prostate cancer remains one of the most frequently diagnosed malignancies in men worldwide, and despite favorable outcomes for localized disease, progression to castration-resistant prostate cancer (CRPC) represents a major clinical challenge associated with poor prognosis. CRPC is characterized by disease progression...